ATE420852T1 - Verfahren und zusammensetzungen zur behandlung oder prävention von bakteriellen infektionen - Google Patents

Verfahren und zusammensetzungen zur behandlung oder prävention von bakteriellen infektionen

Info

Publication number
ATE420852T1
ATE420852T1 AT01274515T AT01274515T ATE420852T1 AT E420852 T1 ATE420852 T1 AT E420852T1 AT 01274515 T AT01274515 T AT 01274515T AT 01274515 T AT01274515 T AT 01274515T AT E420852 T1 ATE420852 T1 AT E420852T1
Authority
AT
Austria
Prior art keywords
compositions
treating
methods
bacterial infections
preventing bacterial
Prior art date
Application number
AT01274515T
Other languages
English (en)
Inventor
Dexu Zhu
Mutsumi Muramatsu
Jianshu Xie
Ni Cheng
Mingwei Wang
Original Assignee
Dexu Zhu
Mutsumi Muramatsu
Jianshu Xie
Ni Cheng
Mingwei Wang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dexu Zhu, Mutsumi Muramatsu, Jianshu Xie, Ni Cheng, Mingwei Wang filed Critical Dexu Zhu
Application granted granted Critical
Publication of ATE420852T1 publication Critical patent/ATE420852T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/18—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/14—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2291/00—Indexing codes associated with group G01N29/00
    • G01N2291/02—Indexing codes associated with the analysed material
    • G01N2291/021—Gases
    • G01N2291/0217—Smoke, combustion gases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2291/00—Indexing codes associated with group G01N29/00
    • G01N2291/04—Wave modes and trajectories
    • G01N2291/042—Wave modes
    • G01N2291/0423—Surface waves, e.g. Rayleigh waves, Love waves

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT01274515T 2001-09-26 2001-10-23 Verfahren und zusammensetzungen zur behandlung oder prävention von bakteriellen infektionen ATE420852T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB011422890A CN1203055C (zh) 2001-09-26 2001-09-26 治疗或预防细菌感染的方法和组合物

Publications (1)

Publication Number Publication Date
ATE420852T1 true ATE420852T1 (de) 2009-01-15

Family

ID=4676742

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01274515T ATE420852T1 (de) 2001-09-26 2001-10-23 Verfahren und zusammensetzungen zur behandlung oder prävention von bakteriellen infektionen

Country Status (10)

Country Link
US (1) US6734212B2 (de)
EP (1) EP1430025B1 (de)
JP (1) JP4102303B2 (de)
KR (1) KR100884848B1 (de)
CN (1) CN1203055C (de)
AT (1) ATE420852T1 (de)
AU (1) AU2002220465B2 (de)
CA (1) CA2460006A1 (de)
DE (1) DE60137459D1 (de)
WO (1) WO2003029201A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07235803A (ja) * 1994-02-25 1995-09-05 Nec Corp 同軸形高電力用低域フィルタ
GB0129260D0 (en) * 2001-12-06 2002-01-23 Eisai London Res Lab Ltd Pharmaceutical compositions and their uses
CN1810777B (zh) * 2005-01-24 2010-09-29 上海东浩医药生物企业有限公司 一类治疗或预防细菌感染的化合物及其制备方法和用途
WO2007143880A1 (fr) * 2006-06-09 2007-12-21 Shanghai East Best Biopharmaceutical Enterprises Co., Ltd. Composés pour la prévention et le traitement des infections bactériennes, leur préparation et utilisation
US8476350B2 (en) * 2008-12-24 2013-07-02 Exxonmobil Research And Engineering Company Triglyceride plasticizer and process of making
US20250228807A1 (en) * 2022-03-27 2025-07-17 Tranexamic Technologies, Llc Tranexamic class arginine and histidine mimics as therapeutic agents
EP4547023A2 (de) * 2022-06-30 2025-05-07 University of Utah Research Foundation Zusammensetzungen und verfahren zur behandlung, prävention oder hemmung einer einfachen anaeroben infektion
CN116735870A (zh) * 2023-05-16 2023-09-12 重庆新赛亚生物科技有限公司 幽门螺杆菌磁微粒化学发光检测试剂、试剂盒、检测方法及应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1905813A1 (de) * 1968-07-04 1970-03-05 Akad Wissenschaften Ddr 3- oder 4-Guanidobenzoesaeurebenzyl- oder -phenylestern und deren Verwendung als Inhibitoren
US4191709A (en) * 1978-02-06 1980-03-04 Imperial Chemical Industries Limited Manufacture of amines from alcohols with zeolite FU-1 catalysts
US4191779A (en) 1978-03-17 1980-03-04 Stanley Drug Products, Inc. Method of treating bacterial infections
AU541738B2 (en) 1979-09-20 1985-01-17 Nippon Chemiphar Co. Ltd. Cyclohexane carboxylic acid derivatives
JPS5869897A (ja) * 1981-10-20 1983-04-26 Gakuzo Tamura Ｄｎａ遺伝子
JPS6229566A (ja) * 1985-07-30 1987-02-07 Taiyo Yakuhin Kogyo Kk 新規グアニジノメチル安息香酸誘導体
US5247084A (en) 1985-11-12 1993-09-21 Ono Pharmaceutical Co., Ltd. Derivatives of p-guanidinobenzoic acid
JPS63218652A (ja) * 1987-03-09 1988-09-12 Taiyo Yakuhin Kogyo Kk 新規グアニジノメチル安息香酸誘導体およびこれを含有する消化性潰瘍治療剤
JPH01139528A (ja) * 1987-11-24 1989-06-01 Showa Denko Kk 抗潰瘍剤
SE463851B (sv) 1988-09-02 1991-02-04 Amsu Ltd Komposition foer behandling av erektil dysfunktion via uretra
US5571674A (en) 1989-09-18 1996-11-05 The Trustees Of Columbia University In The City Of New York DNA oligomers for use in detection of campylobacter pylori and methods of using such DNA oligomers
DE4221256C2 (de) 1992-06-26 1997-07-10 Lancaster Group Ag Galenische Zusammensetzung für die topische Anwendung
DE69532897T2 (de) * 1994-08-30 2005-04-21 Nagase Chemtex Corp Zwischenprodukte für die Herstellung von Guanidinomethylcyclohexancarbonsäure-Estern
US5741511A (en) 1995-04-12 1998-04-21 Sam Yang Co., Ltd. Transdermal drug delivery device for treating erectile dysfunction
JP2000502682A (ja) 1995-12-22 2000-03-07 ローカルメッド インコーポレイテッド 血管新生を促進する成長因子の局所的血管内デリバリー
US5736154A (en) 1996-03-11 1998-04-07 Fuisz Technologies Ltd. Transdermal delivery system
SE9703226D0 (sv) 1997-09-08 1997-09-08 Astra Ab New pharmaceutical composition
US6197801B1 (en) 1998-01-14 2001-03-06 Usa Doctors Products, Inc. Injectable pharmaceutical composition for treatment and reversal of erectile dysfunction
TWI237695B (en) 1999-12-14 2005-08-11 Joy Biomedical Corp Helicobacter pylori antigens in blood

Also Published As

Publication number Publication date
US20030125384A1 (en) 2003-07-03
KR100884848B1 (ko) 2009-02-23
EP1430025A1 (de) 2004-06-23
JP2005504123A (ja) 2005-02-10
CA2460006A1 (en) 2003-04-10
DE60137459D1 (de) 2009-03-05
WO2003029201A1 (en) 2003-04-10
KR20040037089A (ko) 2004-05-04
JP4102303B2 (ja) 2008-06-18
CN1203055C (zh) 2005-05-25
EP1430025B1 (de) 2009-01-14
CN1410419A (zh) 2003-04-16
EP1430025A4 (de) 2005-04-27
AU2002220465B2 (en) 2008-03-20
US6734212B2 (en) 2004-05-11

Similar Documents

Publication Publication Date Title
SE0102315D0 (sv) Compounds
AP2000001942A0 (en) Use of organophosphoric compounds for the therapeutic and preventative treatment of infections.
ATE455092T1 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
EA200601553A1 (ru) Замещенные бензимидазол-, бензтриазол- и бензимидазолон-о-глюкозиды
EA200601555A1 (ru) Замещенные индазол-о-глюкозиды
DE60034871D1 (de) Verfahren und zusammensetzungen zur prevention oder behandlung von krebs und von krebs assoziertem knochenverlust
MXPA05009352A (es) Metodos y composiciones para tratamiento y prevencion de staphylococcus y otras infecciones bacterianas.
ATE335499T1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
UA86599C2 (en) Substituted benzimidazole-, benztriazole- and benzimidazolone-о-glucosides
WO2002007742A8 (en) Bacteriophage having multiple host range
WO2003077828A3 (en) Novel florfenicol-type antibiotics
NO20034056D0 (no) Proliferative sykdommer
ATE531419T1 (de) Vorrichtung zur verabreichung von therapeutischen mitteln
DE60330161D1 (de) Rifalazil zur behandlung von infektionen mit clostridium difficile
EA200600280A1 (ru) Композиции на основе производных липопептидных антибиотиков и способы их применения
MA28613B1 (fr) Macrocycles d'amide antibacteriens
DK1456212T3 (da) 6-aminomorphinanderivater, fremgangsmåder til fremstilling heraf og disses anvendelse
EP1670490A4 (de) Verfahren zur hemmung von bakterienkolonisation
DE60137459D1 (de) Verfahren und zusammensetzungen zur behandlung oder prävention von bakteriellen infektionen
YU89103A (sh) Novi postupak lečenja opsesivno-kompulsivnog poremećaja (okp) i poremećaja povezanih sa okp-om, korišćenjem gvg-a
ATE414082T1 (de) Antibiotische tetrahydro-b-carbolinderivative
ES2169022T3 (es) Utilizacion de derivados de (piridil-metil-sulfinil)-1-h-bencimidazol para el tratamiento de enfermedades provocadas por helicobacter.
NO20010140D0 (no) Kjemotakse-inhiberende protein av Staphylo-Coccus (CHIPS) og dets anvendelse
ATE288498T1 (de) Methoden zur inhibierung von helicobacter pylori
DK0640098T3 (da) S-gen fra hundecoronavirus og anvendelser deraf

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties